Oct 4 |
Exact Sciences Stock Rises After FDA Signs Off On New Cologuard
|
Oct 4 |
Is EXAS Stock a Smart Addition to Your Portfolio Right Now?
|
Oct 4 |
Exact Sciences wins FDA approval for non-invasive colorectal cancer test
|
Oct 4 |
FDA Approves Exact Sciences’ Cologuard Plus Test, Setting a New Benchmark in Non-Invasive Colorectal Cancer Screening
|
Oct 3 |
How to Find Strong Buy Medical Stocks Using the Zacks Rank
|
Sep 26 |
Exact Sciences, Quanterix extend slide after Medicare rates
|
Sep 17 |
The Battle Brewing Over Blood Tests for Cancer
|
Sep 16 |
Exact Sciences gains 6% following data on blood-based colorectal cancer test
|
Sep 16 |
Exact Sciences says data support its colon cancer blood test
|
Sep 16 |
ESMO 2024: Exact Sciences unveils results from cancer algorithm trial
|